Mitotic perturbation is a key mechanism of action of decitabine in myeloid tumor treatmentTomohiro Yabushita, Susumu Goyama, Keita Yamamoto et al.|Cell Reports|2023Cited by 28
Inhibition of TOPORS ubiquitin ligase augments the efficacy of DNA hypomethylating agents through DNMT1 stabilizationSatoshi Kaito, Atsushi Iwama, Kazumasa Aoyama et al.|Nature Communications|2024Cited by 22
Mitotic Perturbation Is a Key Mechanism of Action of Decitabine in Myeloid Tumor TreatmentTomohiro Yabushita, Susumu Goyama, Takumi Chinen et al.|Blood|2022Cited by 3